arrow
A

Akira Ohkoshi

Tohoku University
H指数:13
被引数:590

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world surgical outcomes and prognostic factors in stage III–IVA laryngeal squamous cell carcinoma: a multicenter, retrospective, cohort study in northern Japan

III~IVA期喉鳞状细胞癌的真实世界手术结果及预后因素:一项日本北部多中心、回顾性队列研究

2026-10-240
OAAI
Treatment and prognosis of subglottic cancers: a 10-year, multicenter, retrospective study in northern Japan

声门下癌的治疗与预后:日本北部10年、多中心回顾性研究

2026-05-210
OAAI
Objective response rate predicts survival in recurrent or metastatic head and neck squamous cell carcinoma treated with immune checkpoint blockade but not with targeted therapy: A retrospective multicenter study

客观缓解率预测接受免疫检查点阻断治疗但非靶向治疗的复发性或转移性头颈鳞状细胞癌患者的生存:一项回顾性多中心研究

Cancer
IF5.1
2026-04-210
PRE
Risk factors for aspiration pneumonia related to postoperative chemoradiotherapy for high-risk head and neck cancer: A supplementary analysis of a phase II/III JCOG1008 trial

高风险头颈癌术后放化疗相关吸入性肺炎的危险因素:JCOG1008期II/III临床试验的补充分析

2026-04-180
PRE
Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan

不可切除唾液腺癌根治性放射治疗的疗效:一项日本北部多中心回顾性研究

2025-09-010
PRE
GLP-1R status using validated monoclonal antibody in 689 cases of neuroendocrine neoplasm and its correlation with somatostatin receptor scintigraphy, insulin production, and histological grades
2025-04-010
OAAI
Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiation therapy for locally advanced maxillary sinus cancer (JCOG1212): final analysis

顺铂超选择性动脉灌注联合同期放射治疗局部晚期上颌窦癌的剂量探索与疗效确证试验(JCOG1212):最终分析

2025-02-060
OA
Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008
2024-10-011
PRE
Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial

头颈癌放化疗患者顺铂诱导急性肾损伤的风险预测模型: JCOG1008 II/III期试验的再分析

2024-07-014
PRE
Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients with T4aN0M0
2024-04-016
PRE
Serum selenium predicts achievement of full-dose cisplatin in concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: A prospective, observational study

血清硒可预测全剂量顺铂同步放化疗治疗局部晚期头颈部鳞状细胞癌的疗效: 一项前瞻性观察性研究

2021-10-019
OAAI